Inspire Investing LLC Acquires New Shares in Azenta, Inc. $AZTA

Inspire Investing LLC bought a new position in Azenta, Inc. (NASDAQ:AZTA) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 18,178 shares of the company’s stock, valued at approximately $634,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Green Alpha Advisors LLC grew its holdings in shares of Azenta by 3.5% during the 3rd quarter. Green Alpha Advisors LLC now owns 9,187 shares of the company’s stock valued at $321,000 after acquiring an additional 313 shares in the last quarter. Rockefeller Capital Management L.P. increased its stake in shares of Azenta by 98.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,392 shares of the company’s stock worth $46,000 after acquiring an additional 689 shares during the last quarter. KBC Group NV increased its stake in shares of Azenta by 102.2% in the first quarter. KBC Group NV now owns 2,449 shares of the company’s stock worth $52,000 after acquiring an additional 1,238 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Azenta by 43.8% during the third quarter. GAMMA Investing LLC now owns 4,454 shares of the company’s stock worth $155,000 after acquiring an additional 1,357 shares in the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of Azenta during the second quarter worth $39,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 1.6%

NASDAQ AZTA opened at $41.27 on Friday. The stock has a market capitalization of $1.81 billion, a PE ratio of -14.95 and a beta of 1.52. The company has a 50 day moving average price of $34.92 and a two-hundred day moving average price of $28.50. Azenta, Inc. has a 12-month low of $15.93 and a 12-month high of $46.41.

Azenta (NASDAQ:AZTA) last posted its earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The company had revenue of $161.18 million during the quarter, compared to the consensus estimate of $149.31 million.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $37.00 price objective on shares of Azenta in a research report on Monday, September 14th. Wall Street Zen lowered Azenta from a “buy” rating to a “hold” rating in a research report on Sunday, October 18th. Finally, Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Azenta currently has a consensus rating of “Hold” and a consensus target price of $41.20.

Azenta Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.